When deciding whether to compound a medication, which option best reflects the decision rule?

• A. All of the Above
• B. Whether the Medication Is On the FDA Drug Shortage List
• C. Whether the Patient Can Reasonably Make Up the Dose From Commercially Available Products and Strengths
• D. Whether There Is a Medical Necessity for the Patient to Receive the Compounded Product

Answer: (A)

The decision to compound a medication should be guided by several practical checks that together justify why a compounded product is appropriate. First, there must be a medical necessity for the patient to receive a compounded formulation—some patients need a unique dose, route, or excipient that isn’t available in an approved product. Second, consider drug shortages: if a shortage exists, compounding can provide an essential alternative to maintain patient treatment when commercially available options are limited or unavailable. Third, assess whether the required dose could reasonably be built from commercially available products and strengths; if it can be, compounding may not be necessary or justified.

Weighing all three factors ensures that compounding is reserved for cases where it truly serves patient needs, addresses supply gaps, and remains feasible and safe given available products. That holistic approach is why the all-encompassing option best reflects the decision rule.